Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vita Life Sciences Limited ( (AU:VLS) ) has provided an update.
Vita Life Sciences Limited has announced an update on its ongoing on-market buy-back program, detailing the acquisition of 6,960 ordinary fully paid securities on the previous day, bringing the total number of securities bought back to 195,741. This buy-back initiative is part of the company’s strategy to enhance shareholder value and optimize its capital structure, reflecting a commitment to financial health and market positioning.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development and distribution of vitamins and supplements. The company is known for its range of products that cater to various health needs, targeting consumers seeking to improve their overall well-being.
Average Trading Volume: 13,088
Technical Sentiment Signal: Buy
Current Market Cap: A$133.1M
See more data about VLS stock on TipRanks’ Stock Analysis page.